DNA testing is an incredibly powerful technology for diagnosing infectious diseases, personalizing drugs to your genetics (precision medicine), detecting bacteria and viruses in food and water, testing your pets, and many other applications.
Right now, most DNA tests are performed in centralized labs and results take days or weeks. We're on a mission to revolutionize diagnostics—we believe everyone should have access to fast, accurate, and affordable DNA results.
DNA is in all life on the planet—in every human, the animals we love, the food we eat, the water we drink, and even in the air we breathe. Spartan's DNA diagnostic platform is a solution that knows no boundaries.
Spartan has created a DNA analyzer the size of a coffee cup—the Spartan Cube. You can literally hold it in the palm of your hand. It provides fast and accurate results based on Nobel Prize-winning chemistry called Polymerase Chain Reaction (PCR).
Spartan's RX technology has been cleared by the FDA and is developed and manufactured according to an ISO 13485 quality system. Our products have been used by expert organizations such as the CDC and Mayo Clinic. Our customers include hospitals and Fortune 500 companies. Learn more
Spartan's CYP2C19 test is a great tool because it is easy to perform and provides results in 1 hour. This enables the healthcare team to make rapid, precise treatment decisions leading to better patient outcomes.
November 10th, 2020
Spartan Bioscience is pleased to announce a strengthened executive leadership team and new members of the Board of Directors. These significant additions position Spartan for the next phase of the company’s growth and include a new Chief Executive Officer...
October 29th, 2020
Spartan Bioscience is pleased to announce we have received Investigational Testing Authorization (ITA) from Health Canada for our COVID-19 testing system. ITA allows Spartan to begin its clinical validation studies on symptomatic patients in Canada. These...
September 21st, 2020
Spartan Bioscience has commenced the regulatory process of its revised COVID-19 point-of-care test and submitted an Investigational Testing Authorization (ITA) application to Health Canada for its review and approval. Upon approval, Spartan will commence...